CytoSorb® Reduction of Free Hemoglobin during Cardiac Surgery(REFRESH Trial)
Richard Engelman, MD
Baystate Medical Center
759 Chestnut Street
The purpose of this study is to evaluate the safety and performance of the CytoSorb®device to reduce plasma free hemoglobin when used intraoperatively with cardiopulmonary bypass (CPB) in subjects undergoing cardiac surgery.
Subjects must be undergoing cardiac surgery requiring CPB with ananticipated length of CPB greater than or equal to 3 hours.